Biomedical Engineering Reference
In-Depth Information
. 42.. Liong,. M.,. et. al.,. Multifunctional. inorganic. nanoparticles. for. imaging,. targeting,. and. drug.
delivery,.
Am. Chem. Soc.
,.2,.889,.2008.
. 43.. Bangham,.A.D.,. Standish,. M.M.,. and. Watkins. J.C.,. The. irst. description. of. liposomes,.
J. Mol.
Biol.
,.13,.238,.1965.
. 44.. Wang,. B.,. Siahaan,. T.,. and. Soltero,. R.,.
Drug delivery: principles and applications
,. 1st. ed.,. John.
Wiley.&.Sons,.New.Jersey,.2005.
. 45.. Verma,.A.M.L.,.et.al.,.Liposomes.as.carrier.systems,.
InPharm Communique
,.2,.20,.2009.
. 46.. Torchillin,.V.,.and.Weissig,.V.,.
Liposomes: a practical approach
,.1st.ed.,.Oxford.University.Press,.
Oxford,.1990.
. 47.. Szoka,.F.,.Jr.,.and.Papahadjopoulos,.D.,.Procedure.for.preparation.of.liposomes.with.large.inter-
nal.aqueous.space.and.high.capture.by.reverse-phase.evaporation,.
Proc. Natl. Acad. Sci. USA
,.9,.
4194,.1978.
. 48.. Deamer,. D.,. and. Bangham,.A.D.,. Large. volume. liposomes. by. an. ether. vaporization. method,.
BBA Biomembranes
,
443,.629,.1976.
. 49.. Batzri,.S.,.and.Korn,.E.D.,.Single.bilayer.liposomes.prepared.without.sonication,
BBA Biomembranes
,.
298,.1015,.1973.
. 50.. Barenholz,.Y.,. Liposome. application:. problems. and. prospects,.
Curr. Opin. Colloid Interface
,
6,.
66,.2001
.
. 51.. Pajic-Lijakovic,.I.,.et.al.,.Rheological.quantiication.of.liposomes aggregation,.
Minerva Biotechnol.
,.
17,.245,.2005.
. 52.. Ulrich,. S.A.,. Biophysical. aspects. of. using. liposomes. as. delivery. vehicles,.
Bioscience Rep.
,
22,.
129,.2002.
. 53.. Jemioat-Rzeminska,. M.,. Latowski,. B.,. and. Strzalka,. K.,. Incorporation. of. plastoquinone. and.
ubiquinone.into.liposome.membranes.studied.by.HPLC.analysis..The.effect.of.side.chain.length.
and.redox.state.of.quinine..
Chem. Phys. Lipids
,.110,.85,.2001.
. 54.. Yuba,. E.,. et. al.,. pH-sensitive. fusogenic. polymer-modiied. liposomes. as. a. carrier. of. antigenic.
proteins.for.activation.of.cellular.immunity,.
Biomaterials
,.31,.943,.2010.
. 55.. Lasic,.D.D.,.Liposomes,.
Am. Sci.
,.80,.20,.1992.
. 56.. Janoff,.S.A.,.
Liposome: rational design
,.1st.ed.,.Marcel.Dekker,.New.York,.1999.
. 57.. Barenholz,. Y.,. Relevancy. of. drug. loading. to. liposomal. formulation. therapeutic. eficacy,.
J.
Liposome Res.
,.13,.1,.2003.
. 58.. Linden,. P.K.,. Amphotericin. B. lipid. complex. for. the. treatment. of. invasive. fungal. infections,.
Expert Opin. Pharmacother.
,.4,.2099,.2003.
. 59.. Adler-Moore,.J.,.and.Profitt,.R.T.,.AmBisome:.liposomal.formulation,.structure,.mechanism.of.
action.and.pre-clinical.experience,.
J. Antimicrob. Chemother.
,.49,.21,.2002.
. 60.. Veerareddy,. P.R.,. and. Vobalaboina,. V.,. Lipid-based. formulations. of. amphotericin. B,.
Drugs
Today
,.40,.33,.2004.
. 61.. Hempel,.G.,.et.al.,.Population.pharmacokinetics.of.liposomal.daunorubicin.in.children..
Br. J.
Clin. Pharmacol.
,.56,.370,.2003.
. 62.. Waterhouse,. D.N.,. et. al.,.A. comparison. of. liposomal. formulations. of. doxorubicin. with. drug.
administered.in.free.form:.changing.toxicity.proiles,.
Drug Safety
,.24,.903,.2001.
. 63.. Allen,. T.M.,. and. Martin,. F.J.,. Advantages. of. liposomal. delivery. systems. for. anthracyclines,.
Semin. Oncol.
,.31,.5,.2004.
. 64.. Chowdhary,.R.K.,.Shariff,.I.,.and.Dolphin,.D.,.Drug.release.characteristics.of.lipid.based.benzo-
porphyrin.derivative,.
J. Pharm. Pharm. Sci.
,
6,.13,.2003.
. 65.. www.fda.gov/orphan/designat/list.htm.
. 66.. Lasic,.D.D.,.and.Barenholz,.Y.,.
Handbook of nonmedical applications of liposomes: theory and basic
sciences
,.Vol..1,.CRC.Press,.Boca.Raton,.FL,.1996.
. 67.. Kardesler,. S.,. et. al.,. Topical. delivery. systems. for. the. treatment. of. skin. diseases,. in.
International
Symposium on Biotechnology: development and Trends
,.Ankara,.Turkey,.September.27-30,.2009,.p..112.
. 68.. Demirbag,.B.,.and.Hasirci,.V.,.UV.responsive.drug.delivery.from.suprofen.incorporated.lipo-
somes,. in.
15th International Biomedical Science and Technology Symposium
,. Guzelyurt,. TRNC,.
August.16-19,.2009,.p..84.
